Woxin Pharmaceutical Private limited Through our subsidiary, Syngene, we offer high-end, fully integrated scientific research services that drive innovation, deliver greater efficiency and ensure value creation for clients in the global life sciences sector.

Woxin passion to impact global health has enabled it to touch millions of patient lives. Our goal is to develop affordable blockbuster drugs with the potential to benefit a billion patients.

We are major covering therapeutic segment antibacterials, pain management, antispasmodics, cardiology diabetology, anti ulcerants Antipyretics and life saving drugs etc in different dosage and formlations.